<DOC>
	<DOCNO>NCT00111410</DOCNO>
	<brief_summary>The purpose study estimate effect anakinra , 100 mg daily ( QD ) , development anti-tetanus antibody response subject RA vaccination tetanus diphtheria toxoid injection . In addition , study evaluate general safety profile therapy anakinra , 100 mg QD , subject RA vaccination tetanus diphtheria toxoid injection .</brief_summary>
	<brief_title>Evaluating Effect Anakinra ( r-metHuIL-1ra ) Vaccine AntibodyResponse Subjects With Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Diagnosed RA American College Rheumatology ( ACR ) criteria great equal 12 week Active RA least 3 swollen joint 3 tender/painful joint least one following : Morning stiffness great equal 45 minute ; Creactive protein ( CRP ) great equal 1.5 mg/dL ; Erythrocyte sedimentation rate great equal 28 mm/hr ; Stable methotrexate dose less equal 20 mg/week 8 week prior randomization ; Stable dos nonsteroidal antiinflammatory drug ( NSAIDs ) oral corticosteroid ( less equal 10 mg/day prednisone equivalent ) 4 week prior randomization . Pregnant breastfeed woman Any uncontrolled , clinically significant systemic disease Has total white cell count le 3.5 x 10^9/L , neutrophil count less 2.0 x 10^9/L , platelet count le 125 x 10^9/L hemoglobin ( Hgb ) less 8.0 g/dL screen Abnormal liver function test ( AST/ALT great equal 1.5 x upper limit normal screening ) Serum creatinine great 1.5 x upper limit normal screen Subject recall tetanus toxoid diphtheria vaccination le 10 year prior randomization Has never receive primary tetanus vaccination Any vaccination within 12 week randomization Diseasemodifying antirheumatic drug ( DMARDs ) methotrexate Biologics treat RA within previous 8 week screen ( e.g. , etanercept , infliximab ) Subjects treated anakinra within 4 week prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Rheumatoid Arthritis , Inflammation</keyword>
	<keyword>Interleukin-1 ( IL-1 ) , r-metHuIL-1ra</keyword>
	<keyword>Autoimmune , KineretÂ®</keyword>
	<keyword>Anakinra , Immunex</keyword>
	<keyword>Amgen , Clinical Trials</keyword>
</DOC>